Archive for the ‘diabetes’ Category
Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.
Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”
The authors of a recent paper in the European Journal of Preventive Cardiology on nut intake and the risk of high blood pressure and diabetes have pulled their article from publication for an undisclosed conflict of interest.
Now, you wouldn’t know this unless you were willing to pony up the $32 to read the notice, which is behind a pay wall — something that drives us, well, nuts. But here it is:
The author of a review article on diabetes has been forced to retract the paper after it emerged that he failed to properly credit some of the text — an omission we generally associate with the word plagiarism.
The article, “Colonic flora, probiotics, obesity and diabetes,” was written by Paul Marik, of Eastern Virginia Medical School, and appeared in July 2012 in Frontiers in Endocrinology. It has been cited once, according to Thomson Scientific’s Web of Knowledge.
Here’s the retraction notice: